Causal interpretation of the hazard ratio in randomized clinical trials

IF 2.2 3区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Clinical Trials Pub Date : 2024-04-29 DOI:10.1177/17407745241243308
Michael P Fay, Fan Li
{"title":"Causal interpretation of the hazard ratio in randomized clinical trials","authors":"Michael P Fay, Fan Li","doi":"10.1177/17407745241243308","DOIUrl":null,"url":null,"abstract":"Background:Although the hazard ratio has no straightforward causal interpretation, clinical trialists commonly use it as a measure of treatment effect.Methods:We review the definition and examples of causal estimands. We discuss the causal interpretation of the hazard ratio from a two-arm randomized clinical trial, and the implications of proportional hazards assumptions in the context of potential outcomes. We illustrate the application of these concepts in a synthetic model and in a model of the time-varying effects of COVID-19 vaccination.Results:We define causal estimands as having either an individual-level or population-level interpretation. Difference-in-expectation estimands are both individual-level and population-level estimands, whereas without strong untestable assumptions the causal rate ratio and hazard ratio have only population-level interpretations. We caution users against making an incorrect individual-level interpretation, emphasizing that in general a hazard ratio does not on average change each individual’s hazard by a factor. We discuss a potentially valid interpretation of the constant hazard ratio as a population-level causal effect under the proportional hazards assumption.Conclusion:We conclude that the population-level hazard ratio remains a useful estimand, but one must interpret it with appropriate attention to the underlying causal model. This is especially important for interpreting hazard ratios over time.","PeriodicalId":10685,"journal":{"name":"Clinical Trials","volume":"2012 1","pages":""},"PeriodicalIF":2.2000,"publicationDate":"2024-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Trials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/17407745241243308","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background:Although the hazard ratio has no straightforward causal interpretation, clinical trialists commonly use it as a measure of treatment effect.Methods:We review the definition and examples of causal estimands. We discuss the causal interpretation of the hazard ratio from a two-arm randomized clinical trial, and the implications of proportional hazards assumptions in the context of potential outcomes. We illustrate the application of these concepts in a synthetic model and in a model of the time-varying effects of COVID-19 vaccination.Results:We define causal estimands as having either an individual-level or population-level interpretation. Difference-in-expectation estimands are both individual-level and population-level estimands, whereas without strong untestable assumptions the causal rate ratio and hazard ratio have only population-level interpretations. We caution users against making an incorrect individual-level interpretation, emphasizing that in general a hazard ratio does not on average change each individual’s hazard by a factor. We discuss a potentially valid interpretation of the constant hazard ratio as a population-level causal effect under the proportional hazards assumption.Conclusion:We conclude that the population-level hazard ratio remains a useful estimand, but one must interpret it with appropriate attention to the underlying causal model. This is especially important for interpreting hazard ratios over time.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
随机临床试验中危险比的因果解释
背景:虽然危险比没有直接的因果解释,但临床试验人员通常将其用作治疗效果的衡量标准。方法:我们回顾了因果估计的定义和示例。我们讨论了双臂随机临床试验中危险比的因果解释,以及潜在结果中比例危险假设的含义。我们说明了这些概念在合成模型和 COVID-19 疫苗接种时变效应模型中的应用。期望差异估计值既是个体水平的估计值,也是人群水平的估计值,而在没有强烈的不可检验假设的情况下,因果比率比和危险比只具有人群水平的解释。我们提醒用户不要做出不正确的个体水平解释,并强调一般来说,危险比并不会平均改变每个人的危险系数。我们讨论了在比例危险假设下将恒定危险比解释为人群水平因果效应的潜在有效解释。结论:我们得出结论,人群水平的危险比仍然是一个有用的估计指标,但在解释它时必须适当注意基本的因果模型。这对于解释随时间变化的危险比尤为重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Clinical Trials
Clinical Trials 医学-医学:研究与实验
CiteScore
4.10
自引率
3.70%
发文量
82
审稿时长
6-12 weeks
期刊介绍: Clinical Trials is dedicated to advancing knowledge on the design and conduct of clinical trials related research methodologies. Covering the design, conduct, analysis, synthesis and evaluation of key methodologies, the journal remains on the cusp of the latest topics, including ethics, regulation and policy impact.
期刊最新文献
Challenges in conducting efficacy trials for new COVID-19 vaccines in developed countries. Society for Clinical Trials Data Monitoring Committee initiative website: Closing the gap. A comparison of computational algorithms for the Bayesian analysis of clinical trials. Comparison of Bayesian and frequentist monitoring boundaries motivated by the Multiplatform Randomized Clinical Trial. Efficient designs for three-sequence stepped wedge trials with continuous recruitment.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1